Showing results (51-60 of 332) with videos related to

Sort By:
Pageof 34
Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.
Cytotherapy|March 8, 2021
Non-cryopreserved hematopoietic stem cells in autograft patients with lymphoma: a matched-pair analysis comparing a single center experience with the use of cryopreserved stem cells reported to the European Society for Blood and Marrow Transplantation registryMohamed-Amine Bekadja, Ariane Boumendil, Didier Blaise, et al.
Journal of Hematology & Oncology|February 14, 2023
GVHD occurrence does not reduce AML relapse following PTCy-based haploidentical transplantation: a study from the ALWP of the EBMTFrédéric Baron, Myriam Labopin, Johanna Tischer, et al.
Leukemia Research|July 26, 2005
Administration of mylotarg 4 days after beginning of a chemotherapy including intermediate-dose aracytin and mitoxantrone (MIDAM regimen) produces a high rate of complete hematologic remission in patients with CD33+ primary resistant or relapsed acute myeloid leukemiaPatrice Chevallier, Virginie Roland, Béatrice Mahé, et al.
Vaccines|March 26, 2022
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA VaccineBéatrice Clémenceau, Thierry Guillaume, Marianne Coste-Burel, et al.
British Journal of Haematology|February 14, 2002
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemiaPatrice Chevallier, Dominique Penther, Hervé Avet-Loiseau, et al.
Journal of Hematology & Oncology|June 23, 2017
Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMTFrédéric Baron, Annalisa Ruggeri, Eric Beohou, et al.
Transplantation and Cellular Therapy|July 5, 2021
Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic SyndromeThierry Guillaume, Sylvain Thépot, Pierre Peterlin, et al.
Antimicrobial Agents and Chemotherapy|November 15, 2017
Fungal Prophylaxis with a Gastro-Resistant Posaconazole Tablet for Patients with Hematological Malignancies in the POSANANTES StudyPierre Peterlin, Cécile Chauvin, Steven Le Gouill, et al.
Journal of Medical Virology|April 17, 2020
Clinical and economic impact of treated CMV infection in adult CMV-seropositive patients after allogeneic hematopoietic cell transplantationRégis Peffault De Latour, Patrice Chevallier, Didier Blaise, et al.
Pageof 34